Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 456.97B | 505.98B | 430.16B | 311.12B | 315.39B |
Gross Profit | 42.32B | -157.00M | 32.71B | 22.79B | 20.06B |
EBITDA | 36.88B | -2.03B | 21.34B | -5.29B | 10.33B |
Net Income | 26.99B | -15.83B | 15.19B | -12.63B | 7.99B |
Balance Sheet | |||||
Total Assets | 461.03B | 426.97B | 406.59B | 395.40B | 329.58B |
Cash, Cash Equivalents and Short-Term Investments | 307.28B | 102.07B | 61.24B | 68.80B | 106.99B |
Total Debt | 23.60B | 23.60B | 29.09B | 45.62B | 45.75B |
Total Liabilities | 435.57B | 420.89B | 384.28B | 379.64B | 292.84B |
Stockholders Equity | 23.71B | 4.86B | 22.18B | 15.65B | 36.40B |
Cash Flow | |||||
Free Cash Flow | 55.97B | 58.86B | 41.37B | -27.73B | -22.95B |
Operating Cash Flow | 57.66B | 62.75B | 44.16B | -25.59B | -20.81B |
Investing Cash Flow | -4.18B | -1.57B | 7.89B | -3.79B | -2.25B |
Financing Cash Flow | -298.00M | -5.85B | -17.06B | -4.20B | 9.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | ¥85.47B | 10.40 | 5.47% | 4.90% | 62.09% | ||
82 Outperform | ¥71.30B | 8.69 | 3.43% | 9.78% | 38.89% | ||
78 Outperform | ¥84.16B | 14.07 | 2.68% | 7.19% | 25.44% | ||
72 Outperform | ¥86.75B | 3.16 | 186.66% | ― | -9.69% | ― | |
69 Neutral | ¥95.50B | 16.76 | 2.64% | 10.88% | -29.60% | ||
58 Neutral | HK$14.16B | 4.57 | -3.01% | 6.80% | 3.67% | -54.16% | |
56 Neutral | ¥318.49B | ― | -0.17% | 3.17% | 3.06% | 94.98% |